Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 18, 2024

SELL
$151.44 - $200.09 $757 - $1,000
-5 Reduced 0.04%
12,120 $2.39 Million
Q2 2023

Jul 21, 2023

BUY
$160.94 - $186.23 $48,603 - $56,241
302 Added 2.55%
12,125 $2.09 Million
Q1 2023

Apr 12, 2023

BUY
$145.48 - $175.02 $19,348 - $23,277
133 Added 1.14%
11,823 $1.97 Million
Q4 2022

Jan 23, 2023

SELL
$131.14 - $157.47 $92,978 - $111,646
-709 Reduced 5.72%
11,690 $0
Q3 2022

Oct 24, 2022

BUY
$148.29 - $182.55 $33,661 - $41,438
227 Added 1.86%
12,399 $1.84 Million
Q2 2022

Jul 22, 2022

BUY
$155.97 - $200.09 $2,807 - $3,601
18 Added 0.15%
12,172 $2.09 Million
Q1 2022

May 10, 2022

BUY
$181.39 - $234.03 $206,421 - $266,326
1,138 Added 10.33%
12,154 $2.29 Million
Q4 2021

Jan 26, 2022

SELL
$193.69 - $247.03 $32,346 - $41,254
-167 Reduced 1.49%
11,016 $2.69 Million
Q3 2021

Oct 28, 2021

BUY
$189.29 - $209.69 $71,362 - $79,053
377 Added 3.49%
11,183 $2.17 Million
Q2 2021

Aug 06, 2021

SELL
$155.9 - $187.99 $289,350 - $348,909
-1,856 Reduced 14.66%
10,806 $2.01 Million
Q1 2021

May 13, 2021

BUY
$144.0 - $169.39 $28,512 - $33,539
198 Added 1.59%
12,662 $1.99 Million
Q4 2020

Jan 29, 2021

BUY
$157.07 - $174.35 $341,627 - $379,211
2,175 Added 21.14%
12,464 $2.06 Million
Q4 2018

Feb 15, 2019

SELL
$79.28 - $95.27 $84,908 - $102,034
-1,071 Reduced 9.43%
10,289 $880,000
Q3 2018

Oct 29, 2018

SELL
$83.5 - $93.23 $13,360 - $14,916
-160 Reduced 1.39%
11,360 $1.04 Million
Q2 2018

Aug 14, 2018

BUY
$79.9 - $89.2 $62,322 - $69,576
780 Added 7.26%
11,520 $981,000
Q1 2018

Apr 17, 2018

BUY
$71.51 - $84.69 $43,621 - $51,660
610 Added 6.02%
10,740 $897,000
Q4 2017

Feb 14, 2018

BUY
$63.24 - $72.8 $84,109 - $96,824
1,330 Added 15.11%
10,130 $730,000
Q3 2017

Oct 24, 2017

BUY
$59.73 - $65.4 $525,624 - $575,520
8,800
8,800 $561,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $84.9B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Terra Nova Asset Management LLC Portfolio

Follow Terra Nova Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Terra Nova Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Terra Nova Asset Management LLC with notifications on news.